Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Psychedelics

Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale

By Patricio Liddle
May 29, 4:27 PM
Red Light Holland and PharmAla achieve psilocybin extraction milestone, advancing API development for scalable medical products. Read now!

CSE:MDMA

Read More
3 minute read
  • Biotech
  • Cannabis
  • Psychedelics

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans’ Trips And More

By Lara Goldstein
April 17, 9:13 AM
Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the first two…

AWKNF

Read More
3 minute read
  • Biotech
  • Cannabis
  • News
  • Psychedelics

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More

By Lara Goldstein
March 30, 8:57 AM
Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two…

CMND

Read More
3 minute read
  • Cannabis
  • Financing
  • Global
  • Legal
  • Management
  • Psychedelics

Psychedelics Headlines: Trauma-Informed Care, Valentine’s Day & MDMA, Academics On Drugs And More

By Lara Goldstein
February 15, 11:55 AM
Welcome to Benzinga’s psychedelics headlines roundup. This is our pick of must-read news items concerning the last few…

ATAI

Read More
4 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psyched: Defense Dept.’s Ketamine Trial, Cybin’s Psilocybin, Metabolic Disorders, Reform Update And More

By Lara Goldstein
December 5, 11:12 AM
Defense Dept. Funds Ketamine Study For PTSD Treatment 

ATAI

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Braxia Scientific’s Q2 2024: Cash Burn Over But Income Low, What’s Next For Psychedelics Company?

By Lara Goldstein
December 4, 4:09 PM
Ontario-based Canadian psychedelics company Braxia Scientific Corp. (OTC Pink: BRAXF) filed its interim financial statements and management discussion for the three and six months ended Sept. 30, 2023.  Numbers show:

BRAXF

Read More
2 minute read
  • Cannabis
  • Financing
  • Global
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Red Light Holland, With $12M Cash Balance & Revenue Up 33%, Remains ‘Confident’ In Business Strategy

By Lara Goldstein
November 29, 6:04 PM
Canada-based all-mushroom producer Red Light Holland Corp. (OTCQB: TRUFF) filed its quarterly financial statements and management discussion and analysis for the three and six months ended Sept. 30, 2023. Numbers show:

TRUFF

Read More
4 minute read
  • Cannabis
  • Contracts
  • Financing
  • Global
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Rumors
  • Small Cap

Psyched: Cybin’s Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney’s Memoirs And More

By Lara Goldstein
October 29, 10:48 PM
Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted

ATAI

Read More
2 minute read
  • Cannabis
  • Global
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

U.S. Patent For 3D Movement Data Goes To Red Light Holland Subsidiary, More AI Innovation Ahead

By Lara Goldstein
October 20, 5:25 PM
Canadian mushrooms producer Red Light Holland’s (OTCQB: TRUFF) wholly-owned tech subsidiary Radix Motion received a U.S.

TRUFF

Read More
3 minute read
  • Cannabis
  • Events
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

From Fast-Acting Hemp Extracts To Wiz Khalifa Mushroom Kits: Tracking Progressive Trends In Cannabis & Psychedelics

By Joana Scopel
September 22, 7:37 PM
The world of cannabis and psychedelics is evolving at a rapid pace, with companies introducing groundbreaking products and expanding into new markets.

CRLBF

Posts pagination

1 2 … 5 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service